The DOI matches its Crossref record; 170 of the 171 references it cites were found in a registry or an index.
The Importance of Tau Phosphorylation for Neurodegenerative Diseases
Open accessAbstract
Fibrillar deposits of highly phosphorylated tau are a key pathological feature of several neurodegenerative tauopathies including Alzheimer's disease (AD) and some frontotemporal dementias. Increasing evidence suggests that the presence of these end-stage neurofibrillary lesions do not cause neuronal loss, but rather that alterations to soluble tau proteins induce neurodegeneration. In particular, aberrant tau phosphorylation is acknowledged to be a key disease process, influencing tau structure, distribution, and function in neurons. Although typically described as a cytosolic protein that associates with microtubules and regulates axonal transport, several additional functions of tau have recently been demonstrated, including roles in DNA stabilization, and synaptic function. Most recently, studies examining the trans-synaptic spread of tau pathology in disease models have suggested a potential role for extracellular tau in cell signaling pathways intrinsic to neurodegeneration. Here we review the evidence showing that tau phosphorylation plays a key role in neurodegenerative tauopathies. We also comment on the tractability of altering phosphorylation-dependent tau functions for therapeutic intervention in AD and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Tau has been shown to be associated with synaptic dysfunction, and while tau is normally associated with and stabilizes microtubules, tau phosphorylation results in dissociation from microtubules, tau redistribution to somatodendritic compartments and synaptic dysfunction (Hoover, Reed et al. 2010, Noble, Hanger et al. 2013, Spires-Jones and Hyman 2014).”
From SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain (2026) · cites this paper as Noble, Hanger et al. 2013
In the citing paper
“Because tau phosphorylation is likely to promote axonal degeneration and eventual neuronal death, we analyzed cell death within the brains of our 5xFAD models.”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Noble et al., 2013
In the citing paper
“A marker of progressive AD in both humans and mice is the hyperphosphorylation of the microtubule-stabilizing protein tau. The incidence of tau phosphorylation increases as disease progresses and leads to microtubule de-stabilization and failure of the microtubule architecture, especially within neuronal axons (Frost et al., 2015; Gong and Iqbal, 2008; Noble et al., 2013).”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Noble et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapter 12: What does the Anthropocene hold for citizenship?
(2019) · edoc (University of Basel) · doi:10.1007/978-3 · Cited by 11,533
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
Differential Regulation of Dynein and Kinesin Motor Proteins by Tau
Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–477 of 477
Shi, J., Peng, T., Hu, J., & Shao, H. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2297
Biomarkers of Parkinson’s Disease
Fang, F., Stewart, T., & Zhang, J. (2014) · Springer eBooks · doi:10.1007/978-94-007-7740-8_17-1
Perspective Chapter: Alzheimer - A Complex Genetic Background
Calabrò, M., & Crisafulli, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101455
Najbauer, E. É. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-52
Koychev, I. G., & Gallacher, J. (2020) · doi:10.1093/med/9780198713005.003.0040
Molecular diagnosis of Alzheimer’s disease
Lin, X. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v14i.1834
Yamamoto, T., Okamura, Y., Tsukui, R., Kato, Y., Onizuka, H., & Masui, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108063
Potential Therapeutic Strategies for Muscular Dystrophy
Gaina, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102255
Nanoskalauntersuchungen vom zellulären Metabolismus mittels Sekundärionen-Massenspektrometrie
Karsten, L. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9484
Scopa, C., Barnada, S. M., Cicardi, M. E., Singer, M., Trotti, D., & Trizzino, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.24.517794
Analysis of Adult Hippocampal Neurogenesis in Neurodegenerative disease
HAN, G. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.62147
Catalão, C. H. R., da Costa, L. H. A., dos Santos, J. R., Alberici, L. C., Falconi‐Sobrinho, L. L., Coimbra, N. C., Barichello, T., & Rocha, M. J. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2375120/v1
Deep Learning to Detect the Function of Calmodulin in Alzheimer’s Disease
Dong, L. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5781
Inflammation In Relation to Alzheimer’s Disease and Potential Treatments
Zhou, Z. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v45i.7370
A Novel Pathogenic Tau Conformer Playing Part in Tau Pathology in Human Neurons Upon Aging StressPreprint
Tofigh, N., Agahi, S., Riazi, G. H., Pakdaman, H., Moazzam, M. G., & Shahpasand, K. (2023) · Research Square · doi:10.21203/rs.3.rs-3355775/v1
Kits Performance of Hyla, Hycole and its Reciprocal Crossbreds in Tropical Climates
Brahmantiyo, B., Nuraini, H., Komarudin, K., Pratiwi, N., & Saputra, F. (2023) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20220813130825
Short-Term Effects of Winter Food Supply on the Breeding Performance of the Great Tit (Parus major)
Hwang, H.-S., Lee, J.-K., Eom, T.-K., Lee, D.-H., & Rhim, S.-J. (2023) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20230725081750
Biomarkers for Alzheimer’s Disease
Gaddam, M., Motamarri, E. R., & Sharma, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_4
Chronic Traumatic Encephalopathy and Its Future in Immunotherapy-Based Treatment
Kondaparthi, N. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i4.5862
Acceleration of GSK3α/β Exocytosis Inhibits TauopathyPreprint
He, D., Zhang, X., Su, J., Zhang, Q., Zhao, L., Wu, T.-Y., Ren, H., Jia, R., Lei, X., Hou, W., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4771345
Two major culprits: Amyloidogenic Aβ and non-amyloidogenic tau
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00010-3
Potnuru, L. R., DuBose, A., Nowotarski, M. S., Vigers, M. P., Zhang, B., Han, C.-T., & Han, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.14.606685 · Cited by 1
Markovich, S. W., Frey, B. L., Scalf, M., Shortreed, M. R., & Smith, L. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.23.614558
Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor
Catalão, C. H. R., da Costa, L. H. A., dos Santos, J. R., Alberici, L. C., Falconi‐Sobrinho, L. L., Coimbra, N. C., Dominguini, D., Dal‐Pizzol, F., Barichello, T., & Rocha, M. J. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240217 · Cited by 1
The interplay between tauopathies and neurodegeneration
Milik, B. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00012-9
Molecular and Cellular Mechanisms of Primary Tauopathies
Gong, S., & Gan, L. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0056
Hu, Q., Xu, K. L., Ran, Q., Zhang, W., Gan, C., Fang, Q., & Hui, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5186865
Koychev, I. G., & Gallacher, J. (2020) · doi:10.1093/med/9780198713005.003.0040_update_001
Spectroscopic Profile of Metabolome Dynamics During Rat Cortical Neuronal Differentiation
Almeida, I., Martins, F., Goodfellow, B. J., Nunes, A., & Rebelo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168027 · Cited by 1
Sanghai, N., Behrooz, A. B., Latifi‐Navid, H., Babaei, J. F., & Tranmer, G. K. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1714196
MAPK family members differentially regulate pThr175 tau-mediated pathogenicity
Donison, N. S., Hintermayer, M. A., Palik, J., Fisher, J., Volkening, K., & Strong, M. J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107223
Islamie, R., Myint, S. L. L., Rojanaratha, T., Ritthidej, G. C., Wanakhachornkrai, O., Wattanathamsan, O., & Rodsiri, R. (2023) · Figshare · doi:10.6084/m9.figshare.24013036
Kang, X., Wang, D., Zhang, L., Huang, T., Liu, S., Feng, X., Guo, Y., Zhang, Z., Wang, Z., Ren, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26615083
Smith, E. D., Vo, Q., Giasson, B. I., Borchelt, D. R., Prokop, S., & Chakrabarty, P. (2024) · Figshare · doi:10.6084/m9.figshare.24452633
Barthélemy, N. R., Bateman, R. J., Hirtz, C., Marin, P., Bécher, F., Sato, C., Gabelle, A., & Lehmann, S. (2020) · Figshare · doi:10.6084/m9.figshare.11998815
Barthélemy, N. R., Bateman, R. J., Hirtz, C., Marin, P., Bécher, F., Sato, C., Gabelle, A., & Lehmann, S. (2020) · Figshare · doi:10.6084/m9.figshare.11998812
Islamie, R., Myint, S. L. L., Rojanaratha, T., Ritthidej, G. C., Wanakhachornkrai, O., Wattanathamsan, O., & Rodsiri, R. (2023) · Figshare · doi:10.6084/m9.figshare.24013039
Smith, E. D., Vo, Q., Giasson, B. I., Borchelt, D. R., Prokop, S., & Chakrabarty, P. (2023) · Figshare · doi:10.6084/m9.figshare.24452451
Broderick, P. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-95878-6_7
Liquid–liquid phase separation of tau in Alzheimer’s disease
Rajkhowa, S., & Tripathi, T. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.009
Extracellular Protein Quality Control in Tau Pathology
Bhunia, P. K., Verma, D., Vimal, P., & Kasturi, P. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05834-8
Sepulveda-Diaz, J. E. (2013) · theses.fr (ABES) · doi:10.70675/56c42bcbz41dfz432bzbb78z77110b373285
Drug Discovery for Alzheimer’s Disease: Current Status
Wolfe, M. S. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_186
Les nanotubes comme nouvelle voie de transfert et de propagation de la protéine Tau pathologique
Tardivel, M. (2017) · theses.fr (ABES) · doi:10.70675/0cfcd049z970ez4f2dz8417z195cfabdc00d
Du, M., Ma, S., Bai, L., Mou, X., Gao, Y., Zhang, J., & Chen, Y. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04745-3
Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
Barbereau, C. (2020) · theses.fr (ABES) · doi:10.70675/dfe1802ez70f2z4da6zb3e5z63d1de7a429c
Terras, F. (2020) · doi:10.70675/872df6d1ze1b9z4a8dzb02dzad4656ff10f0
Identification et caractérisation fonctionnelle de nouveaux sites de clivage de la protéine Tau
Derisbourg, M. J. (2015) · theses.fr (ABES) · doi:10.70675/ef5f45b0zf4e8z433fz9beaz8d2cc6de65bc
Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
Danis, C. (2018) · theses.fr (ABES) · doi:10.70675/c783a062zb57bz4024z85d0z509baaed8a1b
Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
Denéchaud, M. (2022) · theses.fr (ABES) · doi:10.70675/623e7224z0cb0z47b1z8a22z549acf553ac0
Ribeiro, L. W. (2023) · theses.fr (ABES) · doi:10.70675/68582d99z4406z4ad4zbd76z15927fb63da5
The role of the α7 nicotinic acetylcholine receptor in a model of amyloid pathology
Santos, D. G. (2024) · theses.fr (ABES) · doi:10.70675/b3ed4de5zcd9ez4421za129z0a05130d86b9
Tau pSer396 and pSer404 Define Distinct Epitope Regions Linked to Different Antibody FunctionsPreprint
Pan, R., Congdon, E. E., Chukwu, J. E., Luo, C. C., Sigurdsson, E. M., & Kong, X. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.16.716390
Water‐Mediated Phosphoryl Wires Stabilize Pathological Tau Fibrils
Potnuru, L. R., DuBose, A., Mon, F., Nowotarski, M. S., Vigers, M. P., Zhang, B., Han, C.-T., Straub, J. E., & Han, S. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.202521499
A Biomarker Out of Context: Understanding High p-tau217 in the Developing Brain
Pal, A., Yadav, H., Yadav, D., Goel, F., & Rajput, M. S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05968-9
Microtubule affinity-regulating kinases in neurodegenerative disorders
Shahwan, M. J., Anwar, S., Alrouji, M., AlOmeir, O., Dinislam, K., & Shamsi, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00014-0
Therapeutic strategies for Tau and Alzheimer’s disease
Karthikeyan, K., & Chinnathambi, S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.06.001
Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases
Akbari, V., & Bahramikia, S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02328-w
McFall-Boegeman, H., Talbot, C., Montalbano, M., Puangmalai, N., Wang, K.-W., Kannan, M., Shi, J., Linning‐Duffy, K., Nick, S., Yan, L., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c00852 · Cited by 1
Preparation and Examination of Hyperphosphorylated Tau Produced by PIMAX System
Hagar, H. C., Wang, K., & Kuo, M. (2026) · Neuromethods · doi:10.1007/978-1-0716-5234-3_3
Sahu, S., Chidamabaram, H., Ananthanarayanan, V., Qureshi, T., Desale, S. E., Chandrashekar, M., Santhoshkumar, R., Mishra, M., & Chinnathambi, S. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00818-x
Nakahara, M., Kataoka, K., Maruyama, T., Nurhamim, M., Zhang, Y., Fukuhara, D., Uchida‐Fukuhara, Y., Islam, M. M., Morita, M., Saito, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177542
Therapeutic targeting of tauopathies: From druggable biology to precision intervention
Zhang, C., Ma, J., Wu, X., Wang, X., Huang, X., Zheng, H., & Zhao, Y. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108432
Li, Z., Li, Y., Liu, R., Zhu, Y. M., Wang, R., Lu, K. P., & Zhou, X. Z. (2026) · Cells · doi:10.3390/cells15181650
Delgado, M., Roja, A., Pareek, O., Penman, S. L., Smith, D., & Thanos, P. K. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2752371
Impact of post-translational modifications in Alzheimer’s disease: An overview
Venkataramaiah, C. (2026) · Current Proteomics · doi:10.1016/j.curpro.2026.100189
Parikh, I. J. (2014) · UKnowledge (University of Kentucky)
Metadata
- Authors
- Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S.
- Affiliations
- King's College London (GB)
- Corresponding author
- Noble, Wendy
- Lovestone, Simon
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 83-83
- ISSN
- 1664-2295 (ISSN-L)
- PMC
- PMC3696910
- OpenAlex
- W2011634611
- Cited by
- 475
- References
- 169
- Citations by year
- 2026: 27 · 2025: 51 · 2024: 56 · 2023: 58 · 2022: 56 · 2021: 56 · 2020: 35 · 2019: 24 · 2018: 28 · 2017: 26 · 2016: 17 · 2015: 19 · 2014: 17 · 2013: 4
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Neurology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0512-10053)
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/K500343/1)
- Directorate for Biological Sciences
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau phosphorylation, tauopathy, Alzheimer's disease, frontotemporal dementia, neurofibrillary tangles, soluble tau, trans-synaptic spread, extracellular tau, synaptic function, DNA stabilization, axonal transport, neurodegeneration, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
